Developing new DNA damage and repair inhibitors on the CLARIOstar Plus

  • Company/University: Artios Pharma, UK
  • Interviewee: Dr Claire McWhirter (Principal Scientist)
  • Products used: CLARIOstar Plus
  • Method: development and characterisation of new inhibitors, endpoint and kinetic fluorescence intensity assays, fluorescence polarisation, luminescence
claire-mcwhirter-thumbnail
Compatible readers
Newsletter Sign-up